ulixacaltamide

News

Praxis looks like it could be filing for approval of two products next year, after its childhood epilepsy drug delivered a win in a pivotal trial.

News

MSD has been rocked by a court judgment ordering it to stop making and selling subcutaneous Keytruda in eight European markets.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.